| X25-01-WXX292 |
Neoagarotetradecaose, Purity≥95%
|
|
| X25-01-WXX293 |
Agaroheptose, Purity≥95%
|
|
| X25-01-WXX294 |
Kappa-carrapentaose trisodium salt, Purity≥95%
|
|
| X25-01-WXX295 |
Kappa-carraundecaose hexasodium salt, Purity≥95%
|
|
| X25-01-WXX296 |
Kappa-carraheptaose tetrasodium salt, Purity≥95%
|
|
| X25-01-WXX297 |
Kappa-carratridecaose heptasodium salt, Purity≥95%
|
|
| X25-01-WXX298 |
Kappa-carranonaose pentasodium salt, Purity≥95%
|
|
| X25-01-WXX299 |
Kappa-carranonadecaose decasodium salt, Purity≥90%
|
|
| X25-01-WXX300 |
Kappa-carraheptadecaose nonasodium salt, Purity≥90%
|
|
| X25-01-WXX301 |
Kappa-carrapentadecaose octasodium salt, Purity≥95%
|
|
| X25-01-WXX302 |
N-Acetylated chitoheptaose, Purity≥90%
|
|
| X25-01-WXX303 |
Chitodecaose decahydrochloride, Purity≥90%
|
|
| X25-01-WXX304 |
N-Acetylated chitopentaose, Purity≥95%
|
|
| X25-01-WXX305 |
Chitononaose nonahydrochloride, Purity 90%
|
|
| X25-01-WXX306 |
Lacto-N-fucopentaose VI, Purity≥95%
|
|
| X25-01-WXX307 |
Neu5Gc, Purity≥95%
|
|
| X25-01-WXX324 |
Methyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranoside, Purity≥95%
|
|
| X25-01-WXX325 |
1,6-Anhydro-4-O-toluenesufonyl-β-D-glucopyranose, Purity≥95%
|
|
| X25-01-WXX326 |
4-Nitrophenyl 2-acetamido-6-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-2-deoxy-α-D-galactopyranoside, Purity≥95%
|
|
| X25-01-WXX327 |
4-Nitrophenyl 2-O-(α-D-mannopyranosyl)-α-D-mannopyranoside, Purity≥95%
|
|
| X25-01-WXX328 |
1,2,O-Isopropylidene-6-O-methylsulfonyl-α-D-glucofuranose, Purity≥95%
|
|
| X25-01-WXX329 |
1-O-Acetyl-2,3,5-tri-O-(4-chlorobenzoyl)-β-D-ribofuranose, Purity≥95%
|
|
| X25-01-WXX457 |
2-Chloro-4-nitrophenyl-β-D-maltotrioside, Purity≥95%
|
|
| X25-01-WXX458 |
Fluorescein di-β-D-glucopyranoside, Purity≥95%
|
|
| X25-01-WXX460 |
6-Bromo-2-naphthyl β-D-galactopyranoside, Purity≥98%
|
|
| X25-01-WXX468 |
4-Nitrophenyl-α-D-maltohexaoside, Purity≥95%
|
|
| X25-01-WXX517 |
(4-Nitrophenyl)-β-D-cellotetraoside, Purity≥95%
|
|
| X25-01-WXX518 |
n-Undecyl β-D-glucopyranoside, Purity≥98%
|
|
| X25-01-WXX529 |
(4-Nitrophenyl)-β-D-cellopentaoside, Purity≥95%
|
|
| X25-01-WXX530 |
(2-Cyclohexylethyl)-β-D-maltoside, Purity≥95%
|
|
| X25-01-WXX531 |
(5-Cyclohexylpentyl)-β-D-maltoside, Purity≥95%
|
|
| X25-01-WXX553 |
Maltotriose monohydrate, Purity≥95%
|
|
| X25-11-YM043 |
4-Methylcoumarinyl-β-D-cellotriosyl, Purity ≥95%
|
|
| X25-11-YM070 |
N-Hydroxysuccinimide agent, Heparin-NHS, Purity ≥95%
|
|
| X25-11-YM071 |
Globo-N-pentaose, Purity ≥95%
|
|
| X25-11-YM072 |
Blood Group Type III/IV H-antigen, Purity ≥95%
|
|
| X25-11-YM073 |
Blood Group Type V B-antigen, Purity ≥95%
|
|
| X25-11-YM074 |
Blood Group Type II H-antigen, Purity ≥95%
|
|
| X25-11-YM075 |
Blood Group Type V H-antigen, Purity ≥95%
|
|
| X25-11-YM076 |
PLGA agent, Heparin-PEG-PLGA, Purity ≥95%
|
|
